semaglutide honduras Tegucigalpa 03 26 2026 Hands Stock Footage Video (100% Royalty-free) 4040910633 Tegucigalpa Honduras 03 26 2026

The REVEAL-1 Cohort is an open-label study in individuals with obesity who have lost at least 15% of their total body weight on a GLP-1 medication and who either need or choose to discontinue GLP-1 therapy

The combined effect supports weight loss and metabolic health more effectively than targeting a single pathway

Dose increases are typically the first step and work for many patients

This analysis predicts whether you're likely a rapid-regainer or sustained-loss responder, helping you and your provider design discontinuation timelines and maintenance strategies matched to your biology

Feeling tired during the day disrupts normal activity patterns, which then interferes with nighttime sleep quality